Market revenue in 2023 | USD 15,295.5 million |
Market revenue in 2030 | USD 26,453.7 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Polyphenylsulfone (ppsu) |
Fastest growing segment | Polypropylene (PP) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Polycarbonate (PC), Liquid Crystal Polymer (LCP), Polyphenylsulfone (PPSU), Polyethersulfone (PES), Polyethylenimine (PEI), Polymethyl Methacrylate (PMMA) |
Key market players worldwide | Röchling Group, Nolato AB Class B, Compagnie de Saint-Gobain SA, SABIC, Orthoplastics, Eastman Chemical Co, Celanese Corp Class A, Dow Inc, Tekni-Plex, Solvay SA, Hmc Polymers Company, Integer Holdings Corp, Trelleborg AB ADR, Avantor Inc, Trinseo PLC, Evonik Industries AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical plastic market will help companies and investors design strategic landscapes.
Polyphenylsulfone (ppsu) was the largest segment with a revenue share of 58.22% in 2023. Horizon Databook has segmented the U.S. medical plastic market based on polyethylene (pe), polypropylene (pp), polycarbonate (pc), liquid crystal polymer (lcp), polyphenylsulfone (ppsu), polyethersulfone (pes), polyethylenimine (pei), polymethyl methacrylate (pmma) covering the revenue growth of each sub-segment from 2018 to 2030.
In the U.S., the frequent increment in costs and reduced margins have severely impacted healthcare providers and health plans. This compelled the government to ensure a significant transformation of healthcare funding and insurance coverage segments in the country through the introduction of ACA and Medicaid.
According to the latest U.S. census, 16.8% of the U.S. population is over the age of 65 years and this number is anticipated to reach 74 million by 2030. People aged over 85 need the most care and their population is growing rapidly.
According to Medicaid and CHIP Payment and Access Commission (MACPAC), it costs about USD 26,000 a year for home care compared to USD 90,000 a year for a nursing home. Increasing investment in healthcare by the government and rising preference for home care are expected to drive the medical plastics market in the U.S. over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. medical plastic market , including forecasts for subscribers. This country databook contains high-level insights into U.S. medical plastic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account